Jack Stover | President and CEO |
Jim Early | CFO |
Yi Chen | H.C. Wainwright |
Pierre Goovaerts | BioMedwaregroup |
Jason McCarthy | Maxim Group |
Suraj Singh | RedChip Companies |
David Veitch | Morgan Stanley |
Good morning everyone. Thank you for joining us for the Interpace Diagnostics Conference Call to review the company's financial results and operations for the third quarter and year-to-date ended September 30, 2017, as well as recent developments. The news release detailing our results was issued and will be available on Interpace's website at http://www.interpacediagnostics.com.
Before we get started, during the course of this conference call, the company will make forward-looking statements. We caution you that any statement that is not a statement of historical fact is a forward-looking statement.